The molecular clock mediates leptin-regulated bone formation

被引:468
作者
Fu, LN
Patel, MS
Bradley, A
Wagner, EF
Karsenty, G [1 ]
机构
[1] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA
[2] Baylor Coll Med, Bone Dis Program, Houston, TX 77030 USA
[3] Baylor Coll Med, Childrens Nutr Res Ctr, Houston, TX 77030 USA
[4] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England
[5] Res Inst Mol Pathol, A-1030 Vienna, Austria
基金
美国国家卫生研究院; 加拿大健康研究院;
关键词
D O I
10.1016/j.cell.2005.06.028
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The hormone leptin is a regulator of bone remodeling, a homeostatic function maintaining bone mass constant. Mice lacking molecular-clock components (Per and Cry), or lacking Per genes in osteoblasts, display high bone mass, suggesting that bone remodeling may also be subject to circadian regulation. Moreover, Per-deficient mice experience a paradoxical increase in bone mass following leptin intracerebroventricular infusion. Thus, clock genes may mediate the leptin-dependent sympathetic regulation of bone formation. We show that expression of clock genes in osteoblasts is regulated by the sympathetic nervous system and leptin. Clock genes mediate the antiproliferative function of sympathetic signaling by inhibiting G1 cyclin expression. Partially antagonizing this inhibitory loop, leptin also upregulates AP-1 gene expression, which promotes cyclin D1 expression, osteoblast proliferation, and bone formation. Thus, leptin determines the extent of bone formation by modulating, via sympathetic signaling, osteoblast proliferation through two antagonistic pathways, one of which involves the molecular clock.
引用
收藏
页码:803 / 815
页数:13
相关论文
共 36 条
[11]   The circadian clock: Pacemaker and tumour suppressor [J].
Fu, LN ;
Lee, CC .
NATURE REVIEWS CANCER, 2003, 3 (05) :350-361
[12]   Minireview: Cyclin D1: Normal and abnormal functions [J].
Fu, MF ;
Wang, CG ;
Li, ZP ;
Sakamaki, T ;
Pestell, RG .
ENDOCRINOLOGY, 2004, 145 (12) :5439-5447
[13]   FOS AND BONE CELL-DEVELOPMENT - LESSONS FROM A NUCLEAR ONCOGENE [J].
GRIGORIADIS, AE ;
WANG, ZQ ;
WAGNER, EF .
TRENDS IN GENETICS, 1995, 11 (11) :436-441
[14]   OSTEOCALCIN IN HUMAN-SERUM - A CIRCADIAN-RHYTHM [J].
GUNDBERG, CM ;
MARKOWITZ, ME ;
MIZRUCHI, M ;
ROSEN, JF .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1985, 60 (04) :736-739
[15]   Increased bone formation and osteosclerosis in mice overexpressing the transcription factor Fra-l [J].
Jochum, W ;
David, JP ;
Elliott, C ;
Wutz, A ;
Plenk, H ;
Matsuo, K ;
Wagner, EF .
NATURE MEDICINE, 2000, 6 (09) :980-984
[16]   The suprachiasmatic nucleus generates the diurnal changes in plasma leptin levels [J].
Kalsbeek, A ;
Fliers, E ;
Romijn, JA ;
la Fleur, SE ;
Wortel, J ;
Bakker, O ;
Endert, E ;
Buijs, RM .
ENDOCRINOLOGY, 2001, 142 (06) :2677-2685
[17]   Cbfa1-independent decrease in osteoblast proliferation, osteopenia, and persistent embryonic eye vascularization in mice deficient in Lrp5, a Wnt coreceptor [J].
Kato, M ;
Patel, MS ;
Levasseur, R ;
Lobov, I ;
Chang, BHJ ;
Glass, DA ;
Hartmann, C ;
Li, L ;
Hwang, TH ;
Brayton, CF ;
Lang, RA ;
Karsenty, G ;
Chan, L .
JOURNAL OF CELL BIOLOGY, 2002, 157 (02) :303-314
[18]   Mice lacking JunB are osteopenic due to cell-autonomous osteoblast and osteoclast defects [J].
Kenner, L ;
Hoebertz, A ;
Beil, T ;
Keon, N ;
Karreth, F ;
Eferl, R ;
Scheuch, H ;
Szremska, A ;
Amling, M ;
Schorpp-Kistner, M ;
Angel, P ;
Wagner, EE .
JOURNAL OF CELL BIOLOGY, 2004, 164 (04) :613-623
[19]   Mammalian circadian biology: Elucidating genome-wide levels of temporal organization [J].
Lowrey, PL ;
Takahashi, JS .
ANNUAL REVIEW OF GENOMICS AND HUMAN GENETICS, 2004, 5 :407-441
[20]   Control mechanism of the circadian clock for timing of cell division in vivo [J].
Matsuo, T ;
Yamaguchi, S ;
Mitsui, S ;
Emi, A ;
Shimoda, F ;
Okamura, H .
SCIENCE, 2003, 302 (5643) :255-259